Pharmacoeconomics: from theory to practice

In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, rationing, patient segmentation, disease management, and pricing model development. Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to more efficiently and rationally leverage these healthcare resources, not by restricting access to necessary services, but by using them more efficiently. This updated volume arms decision makers with the tools they need to make wise choices in an area where the stakes are extremely highthe health of the global population. Key Features: Introduces the major concepts and principles of Pharmacoeconomics Gives updated information about pharmacoeconomic models, value-based pricing, novel modelling methodologies and international utilization of these modalities in government, the pharmaceutical industry, and health care settings Demonstrates the full range of ethical and moral issues, as well as overall public health and commercial concerns that are often involved in decisions entailing pharmacoeconomic issues Presents both theory and methodology discussions, including real-world examples, in each chapter

Preface -- Chapter 1. Introduction to Pharmacoeconomics -- Chapter 2. Decision Modeling Techniques -- Chapter 3. Cost of Illness -- Chapter 4. Markov Modeling in Decision Analysis -- Chapter 5. Retrospective Database Analysis -- Chapter 6. What Is Cost-Minimisation Analysis? -- Chapter 7. Cost-Effectiveness Analysis -- Chapter 8. Budget Impact Analysis -- Chapter 9. Multicriteria Decision Analysis for the Healthcare Decision Maker -- Chapter 10. DICE Simulation: AUnifying Modeling Approach for Pharmacoeconomics -- Chapter 11. Some Problems/Assumptions in Pharmacoeconomic Analysis -- Chapter 12. Patient-Reported Outcome Measures -- Chapter 13. Sensitivity Analysis -- Chapter 14. Use of Pharmacoeconomics in Drug Reimbursement: What Can We Learn from International Experience? -- Chapter 15. Value-Based Pricing of Pharmaceuticals in the US and Europe -- Chapter 16. Pharmacoeconomics in Disease Management: Practical Applications and Persistent Challenges -- Chapter 17. From Machine Learning in Drug Discovery to Pharmacoeconomics -- Chapter 18. Speculations on the Future Challenges and Value of Pharmacoeconomics -- Chapter 19. Pharmacoeconomics in the Era of the Novel Coronavirus.